MedTrace Logo

The Impact of POCUS on Treatment Planning and Prognosis in the ICU

NCT06613464 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-09-26

No results posted yet for this study

Summary

This study aims to understand how using bedside ultrasound in the intensive care unit (ICU) can improve diagnosis and treatment for critically ill patients. When patients are admitted to the ICU, doctors usually rely on various tests and assessments, such as the APACHE-II score, to estimate the severity of their condition and predict their chances of survival. In addition to these tests, we will use bedside ultrasound to examine the lungs, heart, vena cava (a large vein), and optic nerve, which can give us important information about the patient's condition.

By using ultrasound, we can look for things like fluid in the lungs, heart function, or increased pressure in the brain. Based on what we find with the ultrasound, we may adjust treatments, such as changing the amount of fluids given or starting new medications.

We will also compare each patient's condition on the first day and the fifth day, using both ultrasound findings and their APACHE-II score, to see if the ultrasound results have influenced their care and outcomes. The study will include 40 patients, and we will track their progress, including how long they stay on mechanical ventilation, how long they are in the hospital, and their survival after 28 days.

This research will help us learn more about how ultrasound can help doctors make better decisions in the ICU, leading to improved care for critically ill patients.

Conditions

  • All of the Icu Patients Over 18 Years Old Except Pregnant, Trauma and AKI Patients

Interventions

DIAGNOSTIC_TEST

diagnosis confirmation

The patients diagnoses will be confirmed though imaging methods like computed tomography chest x-ray and anamnesis

Sponsors & Collaborators

  • Döndü Genc Moralar

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-16
Primary Completion
2024-01-02
Completion
2024-01-02

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06613464 on ClinicalTrials.gov